Crossover and Double Blind Study with Metformin and Rosiglitazone in Impaired Glucose Tolerance Subjects

Proceedings of the Western Pharmacology Society

Volumn 46, Issue , 2003, Pages 143-147

  Flores Saenz, Jose Luis ^a   Trujillo Arriaga, Hector Miguel ^a   Rivas Vilchis, Jose Federico ^a   Mendez Francisco, Jose Domingo ^b   Alarcon Aguilar, Francisco Javier ^a   Roman Ramos, Ruben ^a  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METFORMIN; ROSIGLITAZONE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCINEMIA; MALE; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CHOLESTEROL, HDL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 0344011428     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Report of the Expert Committee on the Diagnosis and Classification on Diabetes Mellitus: Diabetes Care 20: 1183 (1999).
2. Shaw J, Zimmet P, McCarty D and De Courten M: Diabetes Care 23 (Suppl. 2): B5 (2000).
3. De la Fuente JR: El perfil de salud: Mexico, 1995. Medico Moderno 34: 20 (1995).
4. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE and Little RR: Diabetes Care 21: 518 (1998).
5. Román RR, Flores SJL, Alarcón AF, Contreras WC, Rivas VF and Trujillo AH: Invest Med Intern 27: 9 (2000).
6. Klein R: Diabetes Care 18: 258 (1995).
7. American Diabetes Association: Diabetes Care 25 (Supl. 1): S85 (2002).
8. American Diabetes Association: Diabetes Care 25 (Supl. 1): S90 (2002).
9. Raskin P, Rendell M, Riddlf M, Dole J, Freed M and Rosenstock J: Diabetes Care 24: 1226 (2001).
10. Roberts VL: Diabetes Care (Supl. in Spanish): 16 (1999).
11. United Kingdom Prospective Study 24: Ann Intern Med 128: 165 (1998).
12. Viberti G, Kahan SE, Greene DA, Herman WH, Zinman B, Holman RR, Haffner SM, Levy D, Lachin JM, Berry RA, Heise MA, Jones NP and Freed MI: Diabetes Care 27: 1737 (2002).
13. Groop LC: Insulin Resistance: The Fundamental Trigger of Type II Diabetes. In: Diabetes, Obesity and Metabolism 1 (Suppl 1): S1 (1999).
14. Vestergaard H, Lund S and Pedersen O: J Intern Med 250: 406 (2001).
15. Fonseca V, Rosenstock J, Patwardhan R and Salzman A: JAMA 283: 1695 (2000).
16. Miyazaki Y, Mahankali A, Matzuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Manadarino LJ and Defronzo RA: Diabetes Care 24: 710 (2001).
17. Hällsten K, Virtanen K, Lönnqvist F, Sipilä H, Oksanen A, Viljanen T, Rönnemaa T, Viikari J, Knuuti J and Nuutila P: Diabetes 51: 3479 (2002).
18. Reginato M and Lazar M: Elsevier Science 10: 9 (1999).
19. Gale E: Lancet 357: 1870 (2001).
20. Khan M, Peter J and Xue J: Diabetes Care 25: 708 (2002).
21. Albrektsen T, Frederiksen KS, Holmes W, Boel E, Taylor K and Fleckner J. Diabetes 51: 1042 (2002).
22. Warnick GR, Knopp FH and Branson L: Clin Chem 36, 15 (1990).
23. Lebovitz H, Kreider M and Freed M: Diabetes Care 25: 815 (2002).
24. Nolan J, Ludvik B, Beerdsen P, Joyce M and Olefsky J: New Engl J Med 331: 1188 (1994).
25. Nolan JJ, Jones NP, Patwardhan R and Deacon LF: J British Diab Assoc 17: 287 (2000).
26. Sutton M, Rendell M, Dandona P, Dole J, Murphy K, Patwardhan R, Patel J and Freed M. Diabetes Care 25: 2058 (2002)